Additionally, butyrate (HDAC inhibitor) inhibits SLC7A11 transcription by upregulating ATF3 expression and promoting ferroptosis in osteosarcoma cells, thus alleviating osteosarcoma (Nie et al. 2023). This evidence concerns the gene HDAC9 and osteosarcoma.